Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Sell
22
LDOS Quote, Financials, Valuation and Earnings
Last price:
$145.45
Seasonality move
:
1.5%
Day range:
$143.47 - $145.65
52-week range:
$106.38 - $202.90
Dividend yield:
1.06%
P/E ratio:
16.54x
P/S ratio:
1.23x
P/B ratio:
4.20x
Volume:
1.1M
Avg. volume:
1.7M
1-year change:
34.91%
Market cap:
$19.4B
Revenue:
$15.4B
EPS (TTM):
$8.78
Analysts' Opinion
-
Consensus RatingLeidos Holdings has received a consensus rating of Buy. The company's average rating is a Buy based on 8 Buy ratings, 5 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $192.17, Leidos Holdings has an estimated upside of 32.35% from its current price of $145.20.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $153.00 representing 100% downside risk from its current price of $145.20.
Fair Value
-
According to the consensus of 13 analysts, Leidos Holdings has 32.35% upside to fair value with a price target of $192.17 per share.
LDOS vs. S&P 500
-
Over the past 5 trading days, Leidos Holdings has underperformed the S&P 500 by -6.41% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Leidos Holdings does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Leidos Holdings has grown year-over-year revenues for 25 quarters straight. In the most recent quarter Leidos Holdings reported revenues of $4.2B.
Earnings Growth
-
Leidos Holdings has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Leidos Holdings reported earnings per share of $2.68.
Enterprise value:
22.9B
EV / Invested capital:
2.45x
Price / LTM sales:
1.23x
EV / EBIT:
12.95x
EV / Revenue:
1.41x
PEG ratio (5yr expected):
0.02x
EV / Free cash flow:
18.24x
Price / Operating cash flow:
15.90x
Enterprise value / EBITDA:
11.11x
Gross Profit (TTM):
$2.7B
Return On Assets:
9.29%
Net Income Margin (TTM):
7.37%
Return On Equity:
27.31%
Return On Invested Capital:
13.22%
Operating Margin:
12.29%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $14.2B | $15.2B | $16.3B | $3.9B | $4.2B | |
| Gross Profit | $2.1B | $2.2B | $2.7B | $587M | $762M | |
| Operating Income | $1.1B | $1.2B | $1.8B | $348M | $515M | |
| EBITDA | $1.4B | $857M | $2.1B | -$253M | $587M | |
| Diluted EPS | $4.89 | $1.04 | $8.78 | -$2.91 | $2.68 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3.2B | $3.6B | $3.8B | $4B | $4.7B | |
| Total Assets | $12.3B | $13.3B | $13.1B | $12.8B | $13.3B | |
| Current Liabilities | $3.4B | $3.3B | $4.1B | $3B | $3.8B | |
| Total Liabilities | $8.6B | $9.1B | $9B | $8.6B | $8.7B | |
| Total Equity | $3.7B | $4.2B | $4.1B | $4.2B | $4.7B | |
| Total Debt | $4.5B | $5.1B | $5B | $4.7B | $4.7B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.1B | $986M | $1.4B | $795M | $656M | |
| Cash From Investing | -$92M | -$393M | -$132M | -$52M | -$23M | |
| Cash From Financing | -$799M | -$605M | -$889M | -$249M | -$257M | |
| Free Cash Flow | $970M | $804M | $1.3B | $745M | $633M | |
LDOS
Sector
Market Cap
$19.4B
$764.1M
Price % of 52-Week High
71.56%
78.36%
Dividend Yield
1.06%
0%
Shareholder Yield
4.17%
2.32%
1-Year Price Total Return
34.91%
-1.72%
Beta (5-Year)
0.637
0.899
Dividend yield:
1.06%
Annualized payout:
$1.46
Payout ratio:
17.18%
Growth streak:
5 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$148.51
200-day SMA
Sell
Level
$150.86
Bollinger Bands (100)
Sell
Level
148.14 - 175.14
Chaikin Money Flow
Buy
Level
540.9M
20-day SMA
Sell
Level
$157.07
Relative Strength Index (RSI14)
Sell
Level
27.03
ADX Line
Sell
Level
19.93
Williams %R
Buy
Level
-86.3083
50-day SMA
Sell
Level
$168.60
MACD (12, 26)
Sell
Level
-6.81
25-day Aroon Oscillator
Sell
Level
-80
On Balance Volume
Neutral
Level
401.1M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.7776)
Sell
CA Score
(Annual)
Level (-0.5601)
Buy
Beneish M-Score
(Annual)
Level (-2.8139)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (1.6501)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Leidos Holdings Inc is a technology, engineering, and science company that provides services and solutions in the defense, intelligence, civil, and health markets, both domestically and internationally. Company customer includes the U.S. Department of Defense ("DoD"), the U.S. Intelligence Community, the U.S. Department of Homeland Security ("DHS"), the Federal Aviation Administration ("FAA"), the Department of Veterans Affairs ("VA"), and many other U.S. civilian, state and local government agencies, etc. The company is engaged in three reportable segments; Defense Solutions, Civil, and Health. Defense Solutions provides technologically latest services, solutions, and products to a broad customer base. It generates key revenue from Defense Solutions.
Stock Forecast FAQ
In the current month, LDOS has received 8 Buy ratings 5 Hold ratings, and 0 Sell ratings. The LDOS average analyst price target in the past 3 months is $192.17.
-
Where Will Leidos Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that Leidos Holdings share price will rise to $192.17 per share over the next 12 months.
-
What Do Analysts Say About Leidos Holdings?
Analysts are divided on their view about Leidos Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Leidos Holdings is a Sell and believe this share price will drop from its current level to $153.00.
-
What Is Leidos Holdings's Price Target?
The price target for Leidos Holdings over the next 1-year time period is forecast to be $192.17 according to 13 Wall Street analysts, 8 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is LDOS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Leidos Holdings is a Buy. 8 of 13 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of LDOS?
You can purchase shares of Leidos Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Leidos Holdings shares.
-
What Is The Leidos Holdings Share Price Today?
Leidos Holdings was last trading at $145.45 per share. This represents the most recent stock quote for Leidos Holdings. Yesterday, Leidos Holdings closed at $145.20 per share.
-
How To Buy Leidos Holdings Stock Online?
In order to purchase Leidos Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Sell
40
MSTR alert for Dec 24
MicroStrategy [MSTR] is up 8.05% over the past day.
Sell
26
NUTX alert for Dec 24
Nutex Health [NUTX] is down 0.76% over the past day.
Sell
48
VRNA alert for Dec 24
Verona Pharma PLC [VRNA] is down 0.4% over the past day.
